Pharma Bulletin, Issue 24, September 2013

Pharma Bulletin, Issue 24, September 2013

Pharma Bulletin, Issue 24, September 2013


Related content

In this issue:


  • Entry into Force of Certain Amendments to Licensing Conditions on Import of Medicines is Postponed
  • Amendments to the Procedure for Marginal Price Calculation for Antihypertensive Medicines Entered into Force
  • New Registry of Marginal Wholesale and Referent Price Level for Antihypertensive Medicines
  • Amendments to Technical Regulations regarding Medical Products
  • The MHU Suggests Cancelling the Requirement of GMP Certificate Copy when Registering Immunobiologic Medicines
  • Draft Amendments to Rules of Prescription and Orders for Medicines and Medical Products
  • Draft Law on Establishment of Responsibility for Violation of Terms of Consideration the Issuance of License

    Find the full issue here:




    This Pharma Bulletin is not intended to be of an advisory nature, nor is it intended to be exhaustive or fully comprehensive. Its only purpose is to update the readers on the matters that we consider to be of interest for Pharma businesses.

Connect with us


Request for proposal



KPMG's new digital platform

KPMG International has created a state of the art digital platform that enhances your experience, optimized to discover new and related content.